Back
Spyre Therapeutics, Inc. Stock Predictions
This Company Solves Remote Work with Virtual HQs
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Buy
53
SYRE
Spyre Therapeutics, Inc.
Last Price:
$35.13
Seasonality Move:
-3.15%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Phase of AI Is Not About Chat
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.comSpyre Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Spyre Therapeutics, Inc. has on average historically risen by 10.7% based on the past 9 years of stock performance.
-
Spyre Therapeutics, Inc. has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Spyre Therapeutics, Inc. Stock Undervalued?The current Spyre Therapeutics, Inc. [SYRE] share price is $35.12. The Score for SYRE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
SYRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Spyre Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Spyre Therapeutics, Inc. has on average historically risen by 10.7% based on the past 9 years of stock performance.
Spyre Therapeutics, Inc. Stock Rating
Buy
53
Spyre Therapeutics, Inc. (SYRE)
is a Buy
Is Spyre Therapeutics, Inc. overpriced?
-
Spyre Therapeutics, Inc. has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Spyre Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
spyre.com
52-Week Data
52-Week High:
35.31
52-Week Low:
10.91
Prediction Charts
Market Cap:
2.7B
Price in USD:
35.12
Volume:
790.5K
Beta:
2.45
Technical Analysis
SMA50:
32.48
SMA100:
26.57
SMA200:
21.23
52-Wk Change:
47.19%
Stock Predictions
-
Is Spyre Therapeutics, Inc. stock public?Yes, Spyre Therapeutics, Inc. is a publicly traded company.
-
What is the Spyre Therapeutics, Inc. stock quote today?The Spyre Therapeutics, Inc. stock price is 35.12 USD today.
-
How to buy Spyre Therapeutics, Inc. stock online?You can buy Spyre Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-20 | 32.34 | 33.73 | 33.92 | 31.62 |
| Jan-21 | 33.68 | 33.99 | 34.51 | 33.33 |
| Jan-22 | 33.87 | 34.09 | 35.07 | 33.82 |
| Jan-23 | 33.05 | 32.04 | 34.47 | 31.78 |
| Jan-26 | 31.52 | 32.29 | 33.08 | 31.52 |
| Jan-27 | 32.31 | 33.36 | 33.77 | 32.31 |
| Jan-28 | 33.45 | 33.14 | 34.03 | 32.49 |
| Jan-29 | 32.96 | 33.58 | 33.77 | 32.83 |
| Jan-30 | 33.27 | 31.98 | 33.65 | 31.60 |
| Feb-2 | 31.76 | 32.75 | 33.35 | 30.99 |
| Feb-3 | 32.77 | 33.29 | 33.96 | 32.66 |
| Feb-4 | 33.57 | 32.07 | 34.07 | 30.92 |
| Feb-5 | 31.85 | 32.94 | 33.67 | 31.40 |
| Feb-6 | 33.77 | 35.12 | 35.21 | 33.16 |
Spyre Therapeutics, Inc. Earnings
Spyre Therapeutics, Inc. Earnings Report: Per Share Spyre Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Spyre Therapeutics, Inc. Forecast Revenue Growth
Spyre Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Spyre Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.68 per share, and a decrease next year of $0.05 per share.
* Spyre Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.